TAM
TEVA icon

Tucker Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Tucker Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-100
Closed -$892 – 917
2022
Q3 		$892 Hold
100
– – ﹤0.01% 684
2022
Q2 		$752 Sell
100
-900
-90% -$7.84K ﹤0.01% 564
2022
Q1 		$9.39K Buy
+1,000
New +$8.35K ﹤0.01% 242

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Tucker Asset Management's TEVA Position: Q4 2022 in Review

Tucker Asset Management sold out of Teva Pharmaceuticals (TEVA) in Q4 2022, closing a stake of 100 shares — an estimated $892 sold.

Tucker Asset Management first reported a position in TEVA in Q1 2022 and held it in 3 quarters. The position peaked at $9.39K in Q1 2022. 422 funds tracked by Wall St. Rank hold TEVA as of Q4 2022.

  • Tucker Asset Management reported no remaining Teva Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Tucker Asset Management sold 100 Teva Pharmaceuticals shares in Q4 2022, an estimated $892.
  • Tucker Asset Management first reported a position in Teva Pharmaceuticals in Q1 2022 and held it in 3 quarters.
  • Tucker Asset Management's Teva Pharmaceuticals position peaked at $9.39K in Q1 2022.
  • 422 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2022.

Based on Tucker Asset Management's 13F filing for Q4 2022, filed 11 May 2023.